Evidence map›Paper›PMID 33316155›Full record

ArticleACS chemical biology2021

Structural and Kinetic Analyses Reveal the Dual Inhibition Modes of Ornithine Aminotransferase by (1

Arseniy Butrin, Brett A Beaupre, Noel Kadamandla, Peidong Zhao, Sida Shen, Richard B Silverman, Graham R Moran, Dali Liu

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Inactivation of ornithine aminotransferase by (1Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  3. Information-Rich, Dual-FunctionJournal of the American Chemical Society · 2023
    Article
  4. Article
  5. Article
  6. Turnover and Inactivation Mechanisms for (Journal of the American Chemical Society · 2021
    Article
  7. Remarkable and Unexpected Mechanism for (Journal of the American Chemical Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Arseniy ButrinDepartment of Chemistry and Biochemistry, Loyola University Chicago, 1068 W Sheridan Rd, Chicago, Illinois 60660, United States.
Brett A BeaupreDepartment of Chemistry and Biochemistry, Loyola University Chicago, 1068 W Sheridan Rd, Chicago, Illinois 60660, United States.
Noel KadamandlaDepartment of Chemistry and Biochemistry, Loyola University Chicago, 1068 W Sheridan Rd, Chicago, Illinois 60660, United States.
Peidong ZhaoDepartment of Chemistry and Biochemistry, Loyola University Chicago, 1068 W Sheridan Rd, Chicago, Illinois 60660, United States.
Sida ShenDepartment of Chemistry, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, Center for Developmental Therapeutics, Northwestern University, 2145 Sheridan Rd, Evanston, Illinois 60208, United States.ORCID 0000-0002-0295-2545
Richard B SilvermanDepartment of Chemistry, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, Center for Developmental Therapeutics, Northwestern University, 2145 Sheridan Rd, Evanston, Illinois 60208, United States.ORCID 0000-0001-9034-1084
Graham R MoranDepartment of Chemistry and Biochemistry, Loyola University Chicago, 1068 W Sheridan Rd, Chicago, Illinois 60660, United States.ORCID 0000-0002-6807-1302
Dali LiuDepartment of Chemistry and Biochemistry, Loyola University Chicago, 1068 W Sheridan Rd, Chicago, Illinois 60660, United States.ORCID 0000-0002-7587-703X
Loyola University Chicago · USNorthwestern University · US

Funding

New Inactivators of GABA Aminotransferase for Addiction and EpilepsyR01DA030604 · NIDA · NORTHWESTERN UNIVERSITY · PI SILVERMAN, RICHARD B · 2011 to 2020
$4.0M
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of CancersR01CA260250 · NCI · NORTHWESTERN UNIVERSITY · PI RICHARD B SILVERMAN · 2021 to 2026
$2.3M
NCI NIH HHS R01 CA260250NIDA NIH HHS R01 DA030604
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is the most common form of liver cancer and the leading cause of death among people with cirrhosis. HCC is typically diagnosed in advanced stages when tumors are resistant to both radio- and chemotherapy. Human ornithine aminotransferase (

Indexed as

AnimalsCarcinoma, HepatocellularCell Line, TumorCrystallography, X-RayEnzyme InhibitorsKineticsLiver NeoplasmsMagnetic Resonance SpectroscopyMass SpectrometryMiceMolecular StructureOrnithine-Oxo-Acid TransaminaseXenograft Model Antitumor AssaysEnzyme InhibitorsOAT protein, humanOrnithine-Oxo-Acid Transaminase

Identifiers

PMID33316155
PMCPMC8474141
OpenAlexW3113207920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.